Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2020 1
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: Findings from a large Brazilian cohort.
Marcolino MS, Anschau F, Kopittke L, Pires MC, Barbosa IG, Pereira DN, Ramos LEF, Assunção LFI, Costa ASM, Nogueira MCA, Duani H, Martins KPMP, Moreira LB, Silva CTCAD, Oliveira NR, Ziegelmann PK, Guimarães-Júnior MH, Lima MOSS, Aguiar RLO, Menezes LSM, Oliveira TF, Souza MD, Farace BL, Cimini CCR, Maurílio AO, Guimarães SMM, Araújo SF, Nascimento GF, Silveira DV, Ruschel KB, Oliveira TC, Schwarzbold AV, Nasi LA, Floriani MA, Santos VBD, Ramos CM, Alvarenga JC, Scotton ALBA, Manenti ERF, Crestani GP, Batista JDL, Ponce D, Machado-Rugolo J, Bezerra AFB, Martelli PJL, Vianna HR, Castro LC, Medeiros CRG, Vietta GG, Pereira EC, Chatkin JM, Godoy MF, Delfino-Pereira P, Teixeira AL. Marcolino MS, et al. J Neurol Sci. 2022 Dec 15;443:120485. doi: 10.1016/j.jns.2022.120485. Epub 2022 Nov 9. J Neurol Sci. 2022. PMID: 36375382 Free PMC article.
In the matched analysis, patients with neurological syndromes presented more cases of septic shock (17.0 vs. 13.0%, p = 0.045), intensive care unit admission (45.3 vs. 38.9%, p = 0.023), and mortality (38.7 vs. 32.6%, p = 0.026; and 39.2 vs. 30.3%, p & …
In the matched analysis, patients with neurological syndromes presented more cases of septic shock (17.0 vs. 13.0%, p = 0.045), inten …
Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum.
Monteiro LM, Löbenberg R, Barbosa EJ, de Araujo GLB, Sato PK, Kanashiro E, de Araujo Eliodoro RH, Rocha M, de Freitas VLT, Fotaki N, Bou-Chacra NA. Monteiro LM, et al. Eur J Pharm Sci. 2022 Feb 1;169:106097. doi: 10.1016/j.ejps.2021.106097. Epub 2021 Dec 12. Eur J Pharm Sci. 2022. PMID: 34910988 Free article.
Besides, the V1 dose of 0.3 mg/kg/day for 10 days reduced the parasite burden in 83.4% 18.2% (p <0.05) in the liver. BPQ-NLC showed similar leishmanicidal activity compared to miltefosine. ...
Besides, the V1 dose of 0.3 mg/kg/day for 10 days reduced the parasite burden in 83.4% 18.2% (p <0.05) in the liver. BPQ-NLC showe …
Hospital characteristics associated with COVID-19 mortality: data from the multicenter cohort Brazilian Registry.
Souza-Silva MVR, Ziegelmann PK, Nobre V, Gomes VMR, Etges APBDS, Schwarzbold AV, Nunes AGS, Maurílio AO, Scotton ALBA, Costa ASM, Glaeser AB, Farace BL, Ribeiro BN, Ramos CM, Cimini CCR, de Carvalho CA, Rempel C, Silveira DV, Carazai DDR, Ponce D, Pereira EC, Kroger EMS, Manenti ERF, Cenci EPA, Lucas FB, Dos Santos FC, Anschau F, Botoni FA, Aranha FG, de Aguiar FC, Bartolazzi F, Crestani GP, Vietta GG, Nascimento GF, Noal HC, Duani H, Vianna HR, Guimarães HC, de Alvarenga JC, Chatkin JM, de Morais JDP, Carvalho JDSN, Rugolo JM, Ruschel KB, Gomes LBW, de Oliveira LS, Zandoná LB, Pinheiro LS, Pacheco LS, Menezes LDSM, Sousa LD, de Moura LCS, Santos LEA, Nasi LA, Cabral MAS, Floriani MA, Souza MD, Carneiro M, de Godoy MF, Cardoso MMA, Nogueira MCA, Lima MOSS, de Figueiredo MP, Guimarães-Júnior MH, Sampaio NDCS, de Oliveira NR, Andrade PGS, Assaf PL, Martelli PJL, Martins RC, Valacio RA, Pozza R, Menezes RM, Mourato RLS, de Abreu RM, Silva RF, Francisco SC, Guimarães SMM, Araújo SF, Oliveira TF, Kurtz T, Fereguetti TO, de Oliveira TC, Ribeiro YCNMB, Ramires YC, Polanczyk CA, Marcolino MS. Souza-Silva MVR, et al. Intern Emerg Med. 2022 Nov;17(8):2299-2313. doi: 10.1007/s11739-022-03092-9. Epub 2022 Sep 25. Intern Emerg Med. 2022. PMID: 36153772 Free PMC article.
The first model included all 31 hospitals and showed that a private source of funding (beta = - 0.37; 95% CI - 0.71 to - 0.04; p = 0.029) and location in areas with a high gross domestic product (GDP) per capita (beta = - 0.40; 95% CI - 0.72 to - 0.08; p = 0.014) we …
The first model included all 31 hospitals and showed that a private source of funding (beta = - 0.37; 95% CI - 0.71 to - 0.04; p = 0. …
Differences in the genotype frequencies of genes related to blood pressure regulation - a comparative study between South-West Europe and Peri-equatorial Africa.
Aguiar L, Semente I, Ferreira J, Carvalho A, Silva AP, Caroça C, Caria H, Damasceno A, Laires MJ, Sardinha L, Monteiro C, Mascarenhas MR, Faustino P, Inácio Â, Bicho M. Aguiar L, et al. Afr Health Sci. 2021 Dec;21(4):1669-1676. doi: 10.4314/ahs.v21i4.21. Afr Health Sci. 2021. PMID: 35283964 Free PMC article.
RESULTS: Frequencies of genotypes with the 4a allele in eNOS (p<0.001), the G allele in G6PD (p<0.001), the alpha-3.7 kb in HBA (p <0.001), the C allele in the CYB5R3 (p<0.001) were higher in Peri-equatorial Africa. The Hp 1.1 genotype of H …
RESULTS: Frequencies of genotypes with the 4a allele in eNOS (p<0.001), the G allele in G6PD (p<0.001), the alpha-3.7 kb …
Clinical, immunological, and microbiological analysis of the association between periodontitis and COVID-19: a case-control study.
Bemquerer LM, Oliveira SR, de Arruda JAA, Costa FPD, Miguita L, Bemquerer ALM, de Sena ACVP, de Souza AF, Mendes DF, Schneider AH, Azevedo MCS, Travassos DV, Garlet GP, Cunha FQ, de Aguiar RS, de Souza RP, Gomez RS, Spahr A, Obregon-Miano F, Abreu LG, Costa FO, Silva TA. Bemquerer LM, et al. Odontology. 2024 Jan;112(1):208-220. doi: 10.1007/s10266-023-00811-2. Epub 2023 Apr 14. Odontology. 2024. PMID: 37058199 Free PMC article.
RESULTS: Ninety-nine cases of COVID-19 and 182 controls were included for analysis. Periodontitis was associated with more hospitalization (p = 0.009), more days in the intensive care unit (ICU) (p = 0.042), admission to the semi-ICU (p = 0.047), and greater …
RESULTS: Ninety-nine cases of COVID-19 and 182 controls were included for analysis. Periodontitis was associated with more hospitalization ( …
Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
Yamamoto de Almeida L, Pereira-Martins DA, Lima ASG, Baggio MS, de Araujo Koury LC, Lange AP, Bassi SC, Scheucher PS, Rego EM. Yamamoto de Almeida L, et al. BMC Cancer. 2020 Aug 28;20(1):821. doi: 10.1186/s12885-020-07330-1. BMC Cancer. 2020. PMID: 32859169 Free PMC article.
RESULTS: In non-DS patients, IL-8 plasma levels were significantly reduced in the seventh day of ATRA treatment (34.16; 6.99 to 147.11 pg mL(- 1) in D0 vs. 10.9; 0 to 26.81 pg mL(- 1) in D7; p = 0.02) whereas their levels did not discriminate between DS and non-DS developm …
RESULTS: In non-DS patients, IL-8 plasma levels were significantly reduced in the seventh day of ATRA treatment (34.16; 6.99 to 147.11 pg mL …
Comparison of tube and gel techniques for antibody identification.
Novaretti MC, Silveira EJ, Filho EC, Dorlhiac-Llacer PE, Chamone DA. Novaretti MC, et al. Immunohematology. 2000;16(4):138-41. Immunohematology. 2000. PMID: 15373604
Four hundred and thirty were positive by the two methods: 156 anti-D, 9 anti-C, 68 anti-E, 15 anti-c, 6 anti-e, 61 anti-K, 12 anti-Jka, 17 anti-Dia, 5 anti-S, 73 combination Rh antibodies (2 with anti-K), and 8 other antibody specificities. Based on this study, the gel test is mo …
Four hundred and thirty were positive by the two methods: 156 anti-D, 9 anti-C, 68 anti-E, 15 anti-c, 6 anti-e, 61 anti-K, 12 anti-Jka, 17 a …
A randomized, double-blind, placebo-controlled clinical trial of vitamin A in Mozambican children hospitalized with nonmeasles acute lower respiratory tract infections.
Julien MR, Gomes A, Varandas L, Rodrigues P, Malveiro F, Aguiar P, Kolsteren P, Stuyft P, Hildebrand K, Labadarios D, Ferrinho P. Julien MR, et al. Trop Med Int Health. 1999 Dec;4(12):794-800. doi: 10.1046/j.1365-3156.1999.00493.x. Trop Med Int Health. 1999. PMID: 10632986 Free article. Clinical Trial.
On day 5 the rate of clinical discharge was 88.4% (n = 61/69) in the experimental intervention group and 73.9% (n = 65/88) in the placebo group (P = 0.023). CONCLUSION We found a statistically significant reduction in duration of admission among vitamin A-supplemented chil …
On day 5 the rate of clinical discharge was 88.4% (n = 61/69) in the experimental intervention group and 73.9% (n = 65/88) in the placebo gr …